Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Vadim Alexandre | Liam Gascoigne-Cohen
3 pages
N4 Pharma (N4P.L): COVID-19 research project update | Silence Therapeutics (SLN.L): Half-year results
Companies: SEE MTEC MAST INT EBQ CDGP QBT PHAR HVO TIME SSTY DCTA N4P HEMO CRDL SWT DNM ART AXS
Companies: Silence Therapeutics plc
Companies: MAST EBQ PHAR HVO SSTY N4P HEMO SWT ART
Companies: TXG SYGGF INDVN Z29 TXG FARN 4BB PRM SUN AMS SN/ OMG EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC AREC ONT SLN IMCR ABDX
Companies: WNX IKA N4P VANL BKS CREO MFX B90 AOTI TTA
